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A UVB Wavelength Dependency for Local
Suppression of Recall Immunity in Humans
Demonstrates a Peak at 300 nm
Yasmin J. Matthews1, Gary M. Halliday1, Tai A. Phan1 and Diona L. Damian1
UVB radiation is a potent environmental carcinogen that not only causes mutations in the skin but also
profoundly suppresses skin immune responses. Although this UVB-induced suppression of antitumor
immunity has a key role in skin cancer development, the wavelengths within UVB causing greatest in vivo
immunosuppression in humans are as yet unknown. We have identified a wavelength dependency for
immunosuppression in humans across the UVB spectrum. We established linear dose–response curves for
UV-induced local suppression of recall contact hypersensitivity responses at four wavelengths between 289 and
322nm and found peak immune suppressive effectiveness at 300 nm and no detectable suppression at 322 nm
within a physiologically relevant dose range.
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INTRODUCTION
UVR is the primary cause of skin cancer, which is the most
common malignancy in Caucasian populations (Leiter and
Garbe, 2008). Intrinsic to the carcinogenic properties of UVR
is the capacity to induce immune suppression, which impairs
rejection of UVR-induced skin tumors (Fisher and Kripke,
1977). Both the antitumor immune response and the contact
hypersensitivity (CHS) response are Th1-type reactions
(Cavani et al., 2000; Kennedy and Celis, 2008). Immuniza-
tion to contact antigens and elicitation of immune responses
to these antigens is reduced by UVR in both animals and
humans (reviewed by Phan et al. (2006)). It is likely that both
the initial response to a newly evolved tumor antigen
(primary immunity) and the reactivation of the response over
many years (secondary immunity) will impact on tumor
growth.
UVR is generally classified as UVC (200–290nm), UVB
(290–320 nm), and UVA (320–400nm) (Diffey, 2002). Deter-
mination of the wavelength dependency of effects such as
immunosuppression is important to enable understanding
of the interaction between the environment and health, to
optimize protection from hazardous wavelengths, and to
provide insights into mechanisms and chromophores. Wave-
length dependency for suppression of the induction of
primary sensitization in mice showed maximal suppression
of CHS by UVC (De Fabo and Noonan, 1983; Elmets et al.,
1985), although immune responsiveness to murine fibro-
sarcomas was suppressed by UVC and UVB, but not UVA
(De Fabo and Kripke, 1980). In humans, an action spectrum
for in vivo photoisomerisation of cis-urocanic acid, a medi-
ator of UV immunosuppression, showed a 280–310nm peak
(McLoone et al., 2005). Also in human volunteers, UVB
caused a rapid increase in tumor necrosis factor (Walker and
Young, 2007). The wavelength(s) causing maximal immuno-
suppression in vivo in humans are not yet known.
Allergy to nickel affectsB10% of women and 1% of men,
reflecting greater the exposure of women to costume jewelry
(Meding, 2003). Elicitation of secondary CHS reactions to
nickel in volunteers who are already sensitized this allergen
serves as a feasible and ethical model to investigate UV
immunosuppression in humans (Damian and Halliday,
2002). We recruited healthy, nickel-allergic volunteers to
determine in vivo wavelength dependency of UVB-induced
local suppression of recall immunity.
RESULTS
UVB causes dose–responsive local immunosuppression
UV irradiation did not cause systemic immunosuppression in
our model 2 days after irradiation with low UV doses. To assess
this, we measured nickel-induced erythema (NIE) before the
volunteers were exposed to UV (i.e., pre-irradiation control
NIE) and again on unirradiated skin sites following the
irradiation of other sites on the back (i.e., post-irradiation
control NIE). There was no significant difference between
the pre-irradiation NIE (assessed the week before UV) and the
post-irradiation control NIE (i.e., NIE at unirradiated sites,
measured 48 hours after UV irradiation to other sites on the
back) for any wavelength (Table 1).
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The narrowbands centered at 289, 300, and 310nm
caused significant local suppression of nickel CHS (NIE).
Dose–responses were fitted by a linear relationship between
immune suppression (DNIE) and UV exposure with zero
immune suppression at zero UV exposure (Figure 1; Tables 1
and 2). The 289 nm data contained 15 data points at each of
the 5 doses tested and therefore 75 data points were used for
curve fitting. The Kolmogorov–Smirnov test subsequently
confirmed that this is a good approximation to a straight line
(P40.10 and Runs test P¼ 0.333). The slope of the graph
differed significantly from zero (F-statistic Po0.0001) indi-
cating that this waveband caused immunosuppression in a
linear dose-related manner. Analysis of individual UV doses
by paired Student’s t-tests indicated that significant immuno-
suppression was induced by the 2 highest 289 nm doses, with
this waveband causing 33% immune suppression at
50mJ cm2 (P¼0.009; Figure 1a).
The 300 nm irradiation data contained 20 data points at
each dose tested and therefore 120 data points were used for
curve fitting. The data did not deviate significantly from the
straight line to which it was fitted (KS test P40.10; Runs test
P¼0.4). The slope of the graph differed significantly from
zero (F statistic Po0.0001) indicating that this waveband
caused immunosuppression in a linear dose-related manner.
Table 1. Characteristics of the volunteers, unirradiated controls, and minimum immune suppressive dose (MISD) at
each waveband
Peak wavelength (nm) n-value Mean age Pre-irradiation NIE Post-irradiation control NIE P-value1 MISD (mJ cm2)2
289 15 33 96.5 87.1 0.3 32
300 20 33 86.7 90.8 0.7 23
310 15 33 96.5 85.4 0.3 152
322 11 37 94.8 89.2 0.7 –
1The pre-irradiation NIE was measured in each volunteer before any exposure to UV. This was compared with the non-irradiated control nickel-induced
erythema (NIE) (control reaction at an unirradiated skin site assessed at the time of measurement of NIE at UV irradiated sites) to determine if systemic
immunosuppression had occurred (paired, two-tailed Student’s t-test).
2The MISD was determined as the UV dose causing immunosuppression (DNIE) of 20 erythema units, using linear regression.
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Figure 1. UV wavebands at 289 nm (a), 300 nm (b), 310 nm (c), and 322nm (d) were assessed for their immune suppressive effects in humans. Discrete areas
of skin were exposed to graded doses of narrowband UV in groups of nickel-allergic volunteers. Nickel patch testing was performed 48 hours later in each
irradiated area and also in a non-irradiated control area of skin. Immunosuppression (change in nickel-induced erythema, DNIE) is shown as the comparison
of NIE at irradiated sites with the NIE of unirradiated control sites (results shown as mean±SEM; paired two-tailed Student’s t-tests; *Po0.05, **Po0.01,
***Po0.0001).
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The 300nm narrowband induced 34% immunosuppression
at 40mJ cm2 (P¼0.003; paired Student’s t-test; Figure 1b).
The 310 nm irradiation data contained 15 data points at
each dose (75 data points used for curve fitting). The data did
not deviate significantly from the straight line to which it was
fitted (KS test P40.10; Runs test P¼0.67). The slope of the
graph differed significantly from zero (F-statistic Po0.0001)
indicating that this waveband caused immunosuppression in
a linear dose-related manner. Analysis of individual UV doses
by paired Student’s t-tests indicated the highest 310 nm dose
(400mJ cm2) caused significant immunosuppression of 74%
(Po0.0001; Figure 1c). For ethical reasons, we did not use
higher erythemal doses, as this would have caused substantial
sunburn in our volunteers.
Radiation at 322 nm at doses up to 1500mJ cm2 did not
suppress recall immunity
No significant immunosuppression was observed with
graded doses of 322 nm UVB (paired student’s t-test; Figure
1d). Using all data points, this waveband displayed a
dose–response that did not deviate from linear (KS P40.10
and Runs test P¼ 0.90), and a slope that did not significantly
differ from zero (F-statistic P¼ 0.49 for all wavebands). The
highest dose of 322 nm delivered would require 42 hours
of sunlight in Sydney, Autumn midday conditions (we
measured solar irradiance at 1 nm intervals using an OL754
spectroradiometer, Optronics, Orlando, FL, USA; equivalent
to B1 hour of the COLIPA standard sun) (COLIPA, 1994). In
contrast, immunosuppression was observed with 310 nm
irradiation corresponding to o30minutes of midday Sydney
exposure (B10minutes of COLIPA sunlight).
Wavelength dependency of UVB immunosuppression peaks
at 300 nm
Using linear regression for the UV dose–responses, we deter-
mined the minimum immune suppressive dose (MISD; UV
dose causing threshold immunosuppression of 20 erythema
units) at each waveband. Comparison of these MISDs (i.e.,
1/MISD), using all the data points, from all volunteers, in each
of the dose–response studies, shows the relative wavelength
dependency of UVB immunosuppression in this model
(Figure 2).
The minimal erythema dose (sunburn threshold) with our
289 and 310nm sources was 23.2±6.6mJ cm2 (n¼69,
mean age 37 years) and 202.7±54.6mJ cm2 (n¼70, mean
age 34 years) respectively. Hence, although immunosuppres-
sive effectiveness decreased by only 5 times over this UV
range, erythemal effectiveness decreased by B9 times
(compared with B13 times for the CIE erythemal action
spectrum (COLIPA, 1994). Hence, immunosuppression ap-
pears to be less sensitive to changes in wavelength across this
UV range, compared with UV erythema.
DISCUSSION
As with immunosuppression action spectra in mice (De Fabo
and Noonan, 1983; Elmets et al., 1985), we found that shorter
wavelengths are profoundly immunosuppressive in humans,
with a loss of effect at longer UVB wavelengths. However,
the immune effects of different UVB wavebands must also be
interpreted in the context of their relative amounts in sunlight.
As UVB at 310 nm is 440,000 times more abundant at
ground level than radiation at 290 nm, and B15 times more
abundant than 300 nm radiation (Diffey, 2002), 310 nm
within the UVB range will likely be the largest contributor
to immunosuppression on exposure to sunlight.
Table 2. Immunosuppression observed at each UV
dose and waveband
Peak, k
UV dose
(mJ cm2)
Mean
DNIE P-value
% Immuno-
suppression1
289 10 12.9 0.1 14.8
20 15.5 0.07 17.8
35 21.4 0.04 24.6
50 28.9 0.009 33.2
300 0.25 16.8 0.1 18.5
0.5 11.7 0.1 12.9
2 6.0 0.5 6.6
10 21.6 0.06 23.8
40 31.0 0.003 34.1
310 100 19.9 0.006 23.3
200 16.2 0.02 19.0
300 30.1 0.02 35.2
400 63.4 o0.0001 74.2
322 100 2.3 0.8 –
300 15.1 0.3 19.0
600 0.5 1.0 0.6
1,200 0.6 1.0 –
1,500 7.2 0.5 8.1
1Change in nickel-induced erythema (NIE) compared with NIE of
unirradiated control site.
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Figure 2. The relative wavelength dependency of UV-induced suppression
of recall immunity in humans has a peak at 300 nm. Immune suppressive
effectiveness (one over minimum immune suppression dose (1/MISD) versus
wavelength) has been normalized to 1/MISD at 300 nm.
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The available interference filters for our solar simulator
demonstrated overlap at the lower-intensity ‘‘skirt’’ of each
spectral curve, and this could influence the net immune
effects of each narrowband. The 295–300 and 300–305nm
UVB in our 310 nm source, which contributed 25 and 28%,
respectively, of its erythemal effectiveness, could for example
have increased the level of immunosuppression observed
with this filter. The use of narrower waveband interference
filters would be expected to be able to define a narrower
action spectrum peak. Also, we included only women in
these studies because of the difficulty in recruiting nickel-
allergic men; it is possible that there may be differences in the
intensity if not the peak of UV immunosuppression in men,
who may be more UV susceptible (Damian et al., 2008).
In our studies, neither immune suppression nor erythema
was observed with irradiation at 322 nm. Our highest 322 nm
dose corresponded to B214 hours of Sydney midday sunlight,
and required B50minutes of irradiation for our volunteers,
who are seated upright in from of our solar simulator. Longer
irradiation times were thus not feasible with our equipment.
A number of chromophores are established for the
induction of UVB-induced immunosuppression, in particular
DNA and cis-urocanic acid (De Fabo and Noonan, 1983;
Applegate et al., 1989; Noonan and De Fabo, 1992). Our
UVB peak for immunosuppression matches the UVB action
spectrum for in situ formation of pyrimidine dimers in
humans (300 nm) (Freeman et al., 1989) and approximates
that for cis-urocanic acid (McLoone et al., 2005). UVA is also
immunosuppressive in humans (Damian et al., 1999a;
Sivapirabu et al., 2009) and it is possible that the
chromophore for UVA may be different for this waveband.
Further studies are now indicated to explore the mechanisms
involved and to assess the dose–responsiveness of immuno-
suppression in other models.
MATERIALS AND METHODS
The nickel CHS immune model has previously been described in
detail (Damian and Halliday, 2002). Discrete areas of the lower back
of healthy, nickel-allergic women were exposed to graded doses of
UV using an Oriel 1,000W xenon arc lamp solar simulator (Oriel,
Stratford, CT, USA) fitted with UVB/UVA dichroic mirrors
(280–400 nm) and a series of UV interference filters (Oriel; Figure 3,
see Supplementary Table S1 online).
Forty-eight hours after irradiation, irradiated areas and an
adjacent unirradiated control area were challenged with nickel
sulfate in petrolatum (15mg; Trolab, Reinbek, Germany) at a
concentration previously determined to generate mild CHS re-
sponses in each volunteer (0.0008–5%), placed in Finn Chambers
(Epitest, Tuusula, Finland). NIE at each site was measured 72 hours
later with an erythema meter (Dia-Stron, Andover, UK), which uses
narrowband interference filters to compare hemoglobin reflectance
(546 nm) with the reference signal (632 nm). NIE measured in this
way correlates with concentration of applied nickel (Damian and
Halliday, 2002). By subtracting the erythema index (EI) of adjacent
skin from the EI at sites of nickel challenge (Damian and Halliday,
2002), we calculated NIE at each site. Immunosuppression was then
calculated by subtracting the NIE of irradiated sites from the NIE
of unirradiated control sites. All EI measurements were taken in
triplicate. An initial nickel reaction, elicited the week before
irradiation, was also measured in each volunteer to determine the
optimum nickel concentration for further patch testing and was
compared with the unirradiated control reaction (i.e., measured
concurrently with the other test sites 48 hours after irradiation) to test
for any systemic immunosuppression.
Subjects
All volunteers had their minimal erythema dose to solar-simulated
UV determined (i.e., UVB þ UVA mimicking sunlight) (Damian
and Halliday, 2002) and only those with minimal erythema doses
p7.1 J cm2 were used for these studies. This excluded very dark-
skinned individuals in whom accurate measurement of skin
erythema is difficult (Damian and Halliday, 2002). These studies,
which adhered to the principles of Helsinki Guidelines, were
approved by the Ethics Committees of the South West Sydney Area
Health Service and the University of Sydney, and all volunteers
provided written informed consent.
UV Spectra Narrowband UV spectra were generated using a
series of 4.6 cm diameter Oriel interference filters with half-power
bandwidths from 9 to 15 nm. Four studies were performed with
narrowbands between 289 and 322 nm (Figure 3; Supplementary
Table S1). The spectral irradiance of each narrowband source was
measured at 1 nm intervals with an OL754 spectroradiometer
(Optronics) just before the commencement of each waveband
experiment on each group of volunteers. The spectroradiometer was
calibrated for wavelength and irradiance against standard lamps
(Figure 3). The spectroradiometer was used to mathematically
calibrate an IL700 radiometer (International Light, Newburyport,
MA), by taking simulataneous spectroradiometer and radiometer
readings using an SED240 UVB detector (International Light) with
peak responsivity at 285–295 nm and measurement range between
265 and 332nm. This radiometer, which had thus been calibrated
for each waveband, was then used to rapidly monitor individual
waveband output on a daily basis. The integrated irradiances
±20 nm from the peak wavelength for each narrowband were used
to determine irradiation times for each dose.
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Figure 3. Spectral characteristics of the four narrowband interference filters
were measured at 1 nm intervals. The spectra have been normalized at their
peak wavelengths.
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Data analysis
Statistical analysis and curve fitting was performed with GraphPad
Prism 4.0 (GraphPad Software, San Diego, CA). Initially, UV-induced
immunosuppression was determined at each data point as described
above. The EI at the positive unirradiated control and at each
UV-irradiated site were corrected for background by subtraction of
readings taken at adjacent sites. To determine immunosuppression, the
background-corrected UV irradiated measurement was subtracted
from the background-corrected unirradiated positive control. This
difference in nickel-induced EI (DNIE) is the measure of immuno-
suppression shown in each figure. Significance at each irradiation
dose for each waveband was determined by paired Student’s t-test
comparisons between the unirradiated control and each irradiated,
background-corrected data point. Results from all volunteers in each
group were pooled (i.e., all data points used at each dose) to determine
mean immunosuppression (DNIE) at each UV dose and narrowband.
This enables the generation of more reliable dose–responses than when
dose–responses are generated in each individual (Damian et al., 1999b;
Poon et al., 2003). Significance (Po0.05) was determined using paired,
two-tailed Student’s t-tests (results shown as mean±SEM).
Curve fitting for each waveband was performed using all
individual data points. Curves were fitted as straight lines through
zero by linear regression. Normality tests on the residuals were
performed using a KS test to determine whether the data deviated
from the linear curves. Run tests were also performed to additionally
determine whether the curves significantly deviated from the data.
The MISD was then determined for each waveband, as the UV
dose causing DNIE of 20. We used DNIE of 20 erythema units for
these calculations, as this represents the threshold for reproducible
and significant immunosuppression using this model (Poon et al.,
2003). The MISD for each waveband was determined from the
regression analysis of linear dose–responses. The wavelength
dependency was then shown as 1/MISD versus wavelength.
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